• Activist Investor Pushes Par Pharmaceutical, Inc. to Consider Selling Itself More...

• Merck KGaA (MKGAF.PK) Workers Petition to Keep Plant Open More...

• Patheon Inc. (PTI.TO) to Close UK Plant & Eliminate 91 Jobs More...

• Pfizer Inc. (PFE) to Invest $130 Million in Belgian Facility, to Create 100 New Jobs More...

• BioDiem Ltd. (BDM.AX) and Vivalis Begin Collaboration to Test Production of the LAIV Vector on the EB66® Cell Line More...

• Nuevolution Announces Receipt of Milestone Payment from Boehringer Ingelheim Corporation More...

• Evotec AG (EVTG.F) and 4-Antibody AG Form Strategic Collaboration to Innovate Antibody Selection More...

• Complete Genomics, Inc. Builds Asia-Pacific Presence, Signs Distributor Agreements in Australia, China, Japan and Korea More...

• International AIDS Vaccine Initiative, GlycoMimetics, Inc., andGlycosensors and Diagnostics Collaborate to Develop Novel AIDS Vaccine Candidate More...

• BioMarin Pharmaceutical Inc. (BMRN) Appoints Dan Spiegelman as Executive Vice President and Chief Financial Officer More...

• Teva Pharmaceutical Industries Limited (TEVA) AppointsMichael Hayden as President of Global Research and Development and Chief Scientific Officer More...

• Teva Pharmaceutical Industries Limited (TEVA) AppointsMichael Hayden as President of Global Research and Development and Chief Scientific Officer More...

• Novo Nordisk (NJ) (NVO) Appoints Robert Clark as Vice President, Regulatory Affairs More...

• BASF Acquires Global Leader in Omega-3 Fatty Acids for the Pharmaceutical Industry More...

• Savient Pharmaceuticals, Inc. (SVNT)'s Loss Widens on Higher Krystexxa Costs More...

• Tengion Inc. Reduces Loss More...

• Amarin Corporation PLC (AMRN) Reports First Quarter 2012 Financial Results and Provides Update on Operations More...

• Amyris, Inc. Reports First Quarter 2012 Financial Results More...

• ACADIA Pharmaceuticals, Inc. (ACAD) Reports First Quarter 2012 Financial Results More...

• FDA Advisers Reject Regeneron Pharmaceuticals, Inc. (REGN)'s Arcalyst More...

• FDA Staff Focus on Safety of Arena Pharmaceuticals, Inc. (ARNA) Obesity Pill More...

• Merck KGaA (MKGAF.PK)'s Erbitux Fails in Colon Cancer Study More...

• Gilead Sciences, Inc. (GILD)'s Quad Pill Raises Kidney Questions, FDA Says More...

• Shanghai Generon Initiates a Phase II Trial for Breast Cancer in the US More...

• DARA BioSciences, Inc. Announces New Analysis of Patient Self-Reported Diary Results in a Phase 2a Clinical Trial of KRN5500 in Patients With Cancer and Neuropathic Pain More...

• Auxilium Pharmaceuticals (AUXL) Announces XIAFLEX(R) Peyronie's Phase IIb Study Published in the Journal of Urology More...

• Long Commutes May Be Hazardous to Health, Washington University in St. Louis Study More...

• Prepregnancy Obesity Linked to Child Test Scores, Ohio State University Study More...

• Future Treatment for Nearsightedness - Compact Fluorescent Light Bulbs?University of Alabama at Birmingham Study More...

• Fewer Suicides After Antidepressive Treatment for Schizophrenia, Karolinska Institute Study More...

• Strokes: Drawing Test "May Predict Risks in Older Men," Uppsala Universitet Study More...